Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons. (Q45245260)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael J Kozal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

R D MacArthur

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G Peng

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

R M Novak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M van den Berg-Wolf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L Besch

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

T Yurik

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

B Schmetter

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

C Henley

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M Dehlinger

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

CPRCA 058 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

361-370

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Abacavir hypersensitivity reaction

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Identifiers

10.1310/WEQG-QTHL-DL3X-FTXC

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45245260&oldid=1584895541"